Providers of synthetic dsDNA have two overriding responsibilities in this context:
The Guidance outlines a screening framework that will assist providers in meeting both of these responsibilities. Though certain guidance provided in this document is necessarily framed by U.S. policy and regulations, the Guidance was composed so that fundamental goals, provider responsibilities, and the screening framework could be considered for application by the international community. In particular, though the Select Agents and Toxins and the CCL-listed items that are the primary focus of the Guidance may not be relevant for all countries, the sequence screening framework can be applied to other categories of agents and toxins that may be relevant for other regions.
To request a copy of the Response to Public Comments on the Draft Screening Framework Guidance for Synthetic Double-Stranded DNA Providers, please e-mail your request to email@example.com.